Related Experiment Video

Updated: Jun 10, 2025

Nondestructive Monitoring of Degradable Scaffold-Based Tissue-Engineered Blood Vessel Development Using Optical Coherence Tomography
11:12

Nondestructive Monitoring of Degradable Scaffold-Based Tissue-Engineered Blood Vessel Development Using Optical Coherence Tomography

Published on: October 3, 2018

5.6K

A Decade Later: Unveiling Long-Term Coronary Artery Healing with Optical Coherence Tomography Following

Borja Rivero-Santana1, Santiago Jiménez-Valero1, Alfonso Jurado-Román1

  • 1Cardiology Department, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain; La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain.

The Canadian Journal of Cardiology
|October 14, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

647
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

13.8K

Related Concept Videos

Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3